Valeant Pharmaceuticals: Disruption or Destruction?
Valeant Pharmaceuticals has introduced a new operating model in R&D based on mergers and premium pricing. Is it sustainable?
The HBS Digital Initiative reshapes digital to create a world where technology advances and serves humanity. The DI manages this forum to highlight perspectives from the HBS student community.
Want to learn more about technology and organizations? digital.hbs.edu
Close and dismiss.
Expand.